Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells.

Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, Jin VX, Tseng MJ, Tsai SJ, Chang YS, Wu CS, Sun HS, Tsai KD, Jeng LB, Nephew KP, Huang TH, Hsiao SH, Leu YW.

Cancer Res. 2011 Jul 1;71(13):4653-63. doi: 10.1158/0008-5472.CAN-10-3418. Epub 2011 Apr 25.

PMID:
21518779
[PubMed - indexed for MEDLINE]
Free Article
2.

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.

Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC.

Carcinogenesis. 2004 May;25(5):661-8. Epub 2003 Dec 19.

PMID:
14688019
[PubMed - indexed for MEDLINE]
Free Article
3.

Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.

Rasti M, Tavasoli P, Monabati A, Entezam M.

Iran Biomed J. 2009 Oct;13(4):199-206.

PMID:
19946345
[PubMed - indexed for MEDLINE]
4.

Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.

Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.

Oncol Rep. 2012 Apr;27(4):1135-41. doi: 10.3892/or.2012.1624. Epub 2012 Jan 9.

PMID:
22246327
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.

Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ.

J Natl Cancer Inst. 2004 Feb 18;96(4):294-305.

PMID:
14970278
[PubMed - indexed for MEDLINE]
Free Article
6.

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.

Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP.

Int J Cancer. 2004 May 10;109(6):839-47.

PMID:
15027117
[PubMed - indexed for MEDLINE]
7.

DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination.

Hsiao SH, Lee KD, Hsu CC, Tseng MJ, Jin VX, Sun WS, Hung YC, Yeh KT, Yan PS, Lai YY, Sun HS, Lu YJ, Chang YS, Tsai SJ, Huang TH, Leu YW.

Biochem Biophys Res Commun. 2010 Sep 24;400(3):305-12. doi: 10.1016/j.bbrc.2010.08.048. Epub 2010 Aug 19.

PMID:
20727853
[PubMed - indexed for MEDLINE]
8.

Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.

Zhao G, Qin Q, Zhang J, Liu Y, Deng S, Liu L, Wang B, Tian K, Wang C.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S301-11. doi: 10.1245/s10434-012-2364-9. Epub 2012 May 3.

PMID:
22552606
[PubMed - indexed for MEDLINE]
9.
10.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
[PubMed - indexed for MEDLINE]
11.

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7504-9. Epub 2001 Jun 5.

PMID:
11390984
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

PMID:
23669186
[PubMed - indexed for MEDLINE]
Free Article
13.

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D.

Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.

PMID:
18234960
[PubMed - indexed for MEDLINE]
Free Article
14.

Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.

Bhagat R, Chadaga S, Premalata CS, Ramesh G, Ramesh C, Pallavi VR, Krishnamoorthy L.

Cell Oncol (Dordr). 2012 Dec;35(6):473-9. doi: 10.1007/s13402-012-0106-4. Epub 2012 Oct 10.

PMID:
23055343
[PubMed - indexed for MEDLINE]
15.

[Hypermethylation of Ras association domain family protein 1A, hypermethylated in cancer 1 and p73 genes in hepatocellular carcinoma].

Zhao ZH, Geng XP, Zhu LX, Li HM, Liew CT.

Zhonghua Wai Ke Za Zhi. 2005 Dec 1;43(23):1528-32. Chinese.

PMID:
16412291
[PubMed - indexed for MEDLINE]
16.

Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.

Liu WB, Han F, Du XH, Jiang X, Li YH, Liu Y, Chen HQ, Ao L, Cui ZH, Cao J, Liu JY.

Int J Cancer. 2014 Mar 15;134(6):1311-22. doi: 10.1002/ijc.28472. Epub 2013 Nov 11.

PMID:
24037716
[PubMed - indexed for MEDLINE]
17.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.

Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.

PMID:
19221469
[PubMed - indexed for MEDLINE]
Free Article
18.

Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.

Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.

Mol Carcinog. 2003 Dec;38(4):170-8.

PMID:
14639656
[PubMed - indexed for MEDLINE]
19.

Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.

Gjerstorff M, Burns JS, Nielsen O, Kassem M, Ditzel H.

Am J Pathol. 2009 Jul;175(1):314-23. doi: 10.2353/ajpath.2009.080893. Epub 2009 Jun 4.

PMID:
19498007
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

PMID:
12874023
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk